Author

Bishuang Cai

Icahn School of Medicine at Mount SinaiORCID 0000-0002-2047-9923Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:scRNA-seq· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Fanglin MaiD· 2 shared Neha GuptaiD· 2 shared Oren RomiD· 2 shared Yiwei ZhuiD· 2 shared Amaia Navarro‐CorcueraiD· 1 shared Anthony Wayne OrriD· 1 shared Arif YurdaguliD· 1 shared Brian E. SansburyiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Fanglin MaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Macrophage EHD1 promotes inflammation and stabilizes sortilin to accelerate atherosclerosis

Fanglin Ma, Y Liu, Yang Xu, W Liu, Neha Gupta, Yiwei Zhu, Lieying Xiao, Steven Swee, Irsyad Adam, Erika Zheng, Peipei Ping, James G. Traylor, Oren Rom, Jason Ciril Kovacic, Trevor P. Fidler, , Bishuang Cai

This study shows EHD1 promotes inflammation and stabilizes sortilin in macrophages, accelerating atherosclerosis through enhanced TNFR2-NF-kB signaling and endocytic recycling.

Circulation Research · May 21, 2026Peer-reviewedCell Biology

Therapeutic Activity of Resolvin D1 (RvD1) in Murine MASH

Amaia Navarro‐Corcuera, Yiwei Zhu, Fanglin Ma, Neha Gupta, Haley Asplund, Bruno Cogliati, Jerry E. Chipuk, Oren Rom, Scott L. Friedman, Brian E. Sansbury, Xin Huang, Bishuang Cai

This study investigates how RvD1 reduces inflammation, cell death, and fibrosis in MASH by targeting Stat1, ER stress, and MMP pathways.

JHEP Reports · May 14, 2025Peer-reviewedPharmacology & Toxicology